Synthego and AstraZeneca Team Up for Revolutionary CRISPR Gene Editing Partnership Synthego forms a strategic alliance with AstraZeneca to license a novel CRISPR enzyme, enhancing therapeutic development for global researchers.

Synthego and AstraZeneca Team Up for Revolutionary CRISPR Gene Editing Partnership #USA #AstraZeneca #Redwood_City #CRISPR_solutions #Synthego